Skip to content

PHARMAELA

Active
Private limited companyfounded 2023active for 3 yearsRue Paul Pastur 320, 7390 Quaregnon, BelgiumKBO/BCE: BE 0802.941.155
Summary

The computed 12-month bankruptcy probability of PHARMAELA is 2.2% (moderate). The 2025 annual accounts show negative equity (-€18,810) and a net result of -€30,599. Its solvency ranks better than 19% of 22,595 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€286,114total assets 2025
Staff
1.2 FTE
Equity
-€18,810
Loss
-€30,599
Turnover not published (micro format)
Financial health
51 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.2%
Structure
2025 accounts 26 days early
Why 51raises riskSector: Retail trade (NACE 47)Founded in 2023Negative equity -€18,810lowers riskSize: total assets €286,114Show the evidence

Checked score

Score 2025
51 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 11% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 18-11
equity -6.6% of total assets
Liquidity 11=
short-term debt 79.3% · cash 3.1%
Profitability 5-55
return on assets -10.7%
Bankruptcy probability, 12 months
2.2% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 2.3% 12-2024: 2.6%▲ +0.3 percentage points vs 11-2024 01-2025: 2.8%▲ +0.2 percentage points vs 12-2024 02-2025: 2.8%● unchanged vs 01-2025 03-2025: 2.8%● unchanged vs 02-2025 04-2025: 2.7%▼ -0.1 percentage points vs 03-2025 05-2025: 3.0%▲ +0.3 percentage points vs 04-2025 06-2025: 3.1%▲ +0.1 percentage points vs 05-2025 07-2025: 3.1%● unchanged vs 06-2025highest value 08-2025: 1.9%▼ -1.2 percentage points vs 07-2025 09-2025: 1.9%● unchanged vs 08-2025 10-2025: 1.9%● unchanged vs 09-2025 11-2025: 1.9%● unchanged vs 10-2025 12-2025: 1.9%● unchanged vs 11-2025 01-2026: 1.9%● unchanged vs 12-2025 02-2026: 1.8%▼ -0.1 percentage points vs 01-2026 03-2026: 1.6%▼ -0.2 percentage points vs 02-2026lowest value 04-2026: 1.7%▲ +0.1 percentage points vs 03-2026 05-2026: 1.7%● unchanged vs 04-2026 06-2026: 1.7%● unchanged vs 05-2026 07-2026: 1.8%▲ +0.1 percentage points vs 06-2026 08-2026: 2.2%▲ +0.4 percentage points vs 07-2026 09-2026: 2.2%● unchanged vs 08-2026 10-2026: 2.2%● unchanged vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.85, compared with 0.77 in 2024, below 1; short-term debt: 79.3% and cash: 3.1% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 17% on solvency, 11% on liquidity, 15% on profitability and 2% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €286,114
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity -€18,810
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
2425
2024 to 2025 · latest year -€18,810
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-07-2026, 26 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
26 days early
2024
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 17 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. IncorporationAppointment: ELAMINE Oussama (administrateur non…

Financials · financial year 2025, micro format

Equity
-€18,810
2024 · €11,788
Total assets
€286,114▼ 1.4%
2024 · €290,207
Net result
-€30,599
2024 · €1,788
Working capital
-€33,436▲ 39.6%
2024 · -€55,397
Trend over the years

2024 to 2025, 2 financial years

The operating result turns negative in 2025: a loss of €18,587 after €10,397 in 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€18,587 2025 Net result-€30,599 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€10,397--€18,587
Net result€1,788within the sector's middle half--€30,599below the sector's middle half
Equity€11,788within the sector's middle half--€18,810below the sector's middle half
Total assets€290,207within the sector's middle half-€286,114within the sector's middle half▼ 1.4%
Debt€278,419-€304,924▲ 9.5%
Working capital-€55,397below the sector's middle half--€33,436below the sector's middle half▲ 39.6%
Solvency4.1%within the sector's middle half--6.6%below the sector's middle half▼ 10.6pp
Current ratio0.77below the sector's middle half-0.85below the sector's middle half▲ 0.09
Return on assets (ROA)0.6%within the sector's middle half--10.7%below the sector's middle half▼ 11.3pp
Staff (FTE)1.2-1.2=
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €286,114
Fixed assets €92,522 ▼ 15.5%
Current assets €193,592 ▲ 7.1%
Equity and liabilities
Equity-€18,810
Debt€304,924
Equity is negative: debt (€304,924) exceeds the balance-sheet total (€286,114).
Key figures and ratios
2025 value · change against 2024
EBITDA
-€1,656▼
2024 · €39,968
Cash flow
-€13,668▼
2024 · €31,359
Quick ratio
0.37▲
2024 · 0.32
Interest coverage
-0.13▼
2024 · 4.83
Debt ≤ 1 year
€227,028▼
2024 · €236,152
Debt > 1 year
€70,696▲
2024 · €39,868
Income taxes
-€90▼
2024 · €1,000
Staff costs
€51,078▼
2024 · €75,787
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 7,639 companies that looked in July 2024 the way this one looks now, 8.8% went bankrupt within 24 months and 84.8% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.8% went bankrupt
5.6% stopped otherwise
84.8% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 2.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet Code20242025
Assets
Total assets20/58€290,207€286,114▼
Fixed assets21/28€109,453€92,522▼
Intangible fixed assets21€23,163€16,623▼
Tangible fixed assets22/27€86,085€75,695▼
Furniture and vehicles24€669€278▼
Other tangible fixed assets26€85,417€75,417▼
Financial fixed assets28€205€205=
Current assets29/58€180,754€193,592▲
Stocks and contracts in progress3€105,327€108,963▲
Stocks30/36€105,327€108,963▲
Amounts receivable within one year40/41€61,782€74,886▲
Trade receivables40€57,952€42,799▼
Other amounts receivable41€3,830€32,087▲
Cash at bank and in hand54/58€13,472€8,836▼
Deferred charges and accrued income490/1€173€907▲
Equity and liabilities
Total equity and liabilities10/49€290,207€286,114▼
Equity10/15€11,788-€18,810▼
Contributions10/11€10,000€10,000=
Profit (loss) carried forward14€1,788-€28,810▼
Amounts payable17/49€278,419€304,924▲
Amounts payable after more than one year17€39,868€70,696▲
Financial debts170/4-€47,471
Other amounts payable178/9€39,868€23,226▼
Amounts payable within one year42/48€236,152€227,028▼
Current portion of amounts payable after more than one year42€24,941€44,084▲
Trade debts44€189,848€171,436▼
Suppliers440/4€189,848€171,436▼
Taxes, remuneration and social security45€18,800€11,509▼
Taxes450/3€3,461€455▼
Remuneration and social security454/9€15,339€11,053▼
Other amounts payable47/48€2,564-
Accrued charges and deferred income492/3€2,400€7,200▲
Income statement Code20242025
Remuneration, social security and pensions62€75,787€51,078▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,571€16,931▼
Other operating charges640/8€6,186€2,047▼
Gross operating margin9900€121,940€51,469▼
Operating profit (loss)9901€10,397-€18,587▼
Financial income75/76B€669€994▲
Recurring financial income75€669€994▲
Financial charges65/66B€8,278€13,097▲
Recurring financial charges65€8,278€13,097▲
Profit (loss) for the period before taxes9903€2,788-€30,689▼
Income taxes67/77€1,000-€90▼
Profit (loss) for the period9904€1,788-€30,599▼
Profit (loss) for the period to be appropriated9905€1,788-€30,599▼
Appropriation of the result
Profit (loss) to be appropriated9906€1,788-€28,810▼
Profit (loss) brought forward from the previous period14P-€1,788

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Remuneration, social security and pensions62€75,787€51,078▼ 32.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,571€16,931▼ 42.7%
Other operating charges640/8€6,186€2,047▼ 66.9%
Gross operating margin9900€121,940€51,469▼ 57.8%
Operating profit (loss)9901€10,397-€18,587-
Financial income75/76B€669€994▲ 48.5%
Recurring financial income75€669€994▲ 48.5%
Financial charges65/66B€8,278€13,097▲ 58.2%
Recurring financial charges65€8,278€13,097▲ 58.2%
Profit (loss) for the period before taxes9903€2,788-€30,689-
Income taxes67/77€1,000-€90-
Profit (loss) for the period9904€1,788-€30,599-
Profit (loss) for the period to be appropriated9905€1,788-€30,599-
Line20242025Change
Assets
Total assets20/58€290,207€286,114▼ 1.4%
Fixed assets21/28€109,453€92,522▼ 15.5%
Intangible fixed assets21€23,163€16,623▼ 28.2%
Tangible fixed assets22/27€86,085€75,695▼ 12.1%
Furniture and vehicles24€669€278▼ 58.4%
Other tangible fixed assets26€85,417€75,417▼ 11.7%
Financial fixed assets28€205€205=
Current assets29/58€180,754€193,592▲ 7.1%
Stocks and contracts in progress3€105,327€108,963▲ 3.5%
Stocks30/36€105,327€108,963▲ 3.5%
Amounts receivable within one year40/41€61,782€74,886▲ 21.2%
Trade receivables40€57,952€42,799▼ 26.1%
Other amounts receivable41€3,830€32,087▲ 738%
Cash at bank and in hand54/58€13,472€8,836▼ 34.4%
Deferred charges and accrued income490/1€173€907▲ 425%
Equity and liabilities
Total equity and liabilities10/49€290,207€286,114▼ 1.4%
Equity10/15€11,788-€18,810-
Contributions10/11€10,000€10,000=
Profit (loss) carried forward14€1,788-€28,810-
Amounts payable17/49€278,419€304,924▲ 9.5%
Amounts payable after more than one year17€39,868€70,696▲ 77.3%
Financial debts170/4-€47,471-
Other amounts payable178/9€39,868€23,226▼ 41.7%
Amounts payable within one year42/48€236,152€227,028▼ 3.9%
Current portion of amounts payable after more than one year42€24,941€44,084▲ 76.8%
Trade debts44€189,848€171,436▼ 9.7%
Suppliers440/4€189,848€171,436▼ 9.7%
Taxes, remuneration and social security45€18,800€11,509▼ 38.8%
Taxes450/3€3,461€455▼ 86.8%
Remuneration and social security454/9€15,339€11,053▼ 27.9%
Other amounts payable47/48€2,564--
Accrued charges and deferred income492/3€2,400€7,200▲ 200%
Line20242025Change
Profit (loss) for the period9904€1,788-€30,599-
+ Depreciation and write-downs630€29,571€16,931▼ 42.7%
Operating cash flow (approximation)€31,359-€13,668-
Investment in fixed assets (approximation)-€0-
Change in cash--€4,637-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2025 micro format 05-07-2026 2026-00263952
31-12-2024 micro format 24-07-2025 2025-00326766

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,205 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,896. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2023
ELAMINE Oussama
Administrateur non statutaire · since 22-06-2023
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2023, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
ELAMINE Oussama
  • Administrateur non statutaire, from 22-06-2023 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 22-06-2023 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 22-06-2023 Incorporation · €10,000

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

PHARMAELA was incorporated on 20 June 2023 as a private limited company by two natural persons, with a starting capital of €10,000.12 Since 2023, ELAMINE Oussama has served as administrateur non statutaire of the company.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-06-2023
  3. 3National Bank, annual accounts 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
05-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
24-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2023
22-06
Gazette deed Incorporation
Appointment: ELAMINE Oussama (administrateur non statutaire) · Founder · Founding capital10 facts ▸
  • Founder, ELAMINE Abderrahim
  • Founder, ELAMINE Oussama
  • Incorporation, “PHARMAELA” (deed in French)
  • Founding capital, €10,000
  • Capital
  • Other provision, “conformément_loi, effectivité_décisions_finales” (deed in French)
  • Registered office clause, “Rue Paul Pastur 320 à 7390 Quaregnon” (deed in French)
  • Board rule, 1
  • Director appointment, ELAMINE Oussama (administrateur non statutaire)
  • Pre-incorporation commitments, “takeover, engagements_obligations_activités_entrepris_nom_compte_société_formation” (deed in French)
Gazette deedNBB filing
1 of 1 deed read

Register details

Identification
Legal formPrivate limited company
Founded20-06-2023
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
47789Other retail sale of new goods
Contact
E-mail oelapharma@gmail.com
Phone +32487152652
E-invoicing
Reachable via Peppol
Peppol ID 0208:0802941155
Also 9925:BE0802941155
Registered 03-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Quaregnon · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
279 m²
Building footprint
116 m²
Parcel 53065A0782/00E003, Wallonia. Linked by address, not a title deed.
4 companies at this address See who is registered here
1 establishment unit
PHARMAELA
Rue Paul Pastur 320, 7390 QuaregnonRetail sale of pharmaceutical products
since 2023unit no. 2.346.870.755
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
53065A0782/00E003 Wallonia 279 m² 1 · 116 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
PHARMAELA
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Région Wallonne, pour autant que cette décision n’entraîne pas de changement en matière de régime linguistique applicable à la société” (deed in French)

deed of 22-06-2023

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation, un ou plusieurs administrateurs” (deed in French)

deed of 22-06-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Nominatives, inscrites dans le registre des actions nominatives avec les mentions requises par le Code des sociétés et des associations” (deed in French)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
One provision in the deed

deed of 22-06-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Tuesday of June

deed of 22-06-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Modifications statuts, tout temps” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Présents_statuts, si_aucun_autre_liquidateur_désigné” (deed in French)

deed of 22-06-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Appels de fonds et libération des actions, détermine librement,au fur et à mesure des besoins de la société et aux époques qu’il jugera…” (deed in French)
Other provision: “Apport en numéraire avec émission de nouvelles actions et droit de préférence, portés à la connaissance des actionnaires par courrier…” (deed in French)
Other provision: “Remuneration des administrateurs, fixe ou proportionnelle” (deed in French)
Other provision: “Gestion journaliere, organe d administration” (deed in French)
Other provision: “Controle de la societe, un ou plusieurs commissaires” (deed in French)
Other provision: “11:00, tenue et convocation assemblee generale” (deed in French)
Other provision: “Délibérations_assemblée_générale, actions sans droit vote” (deed in French)
Other provision: “Organe_d’administration, ordinaire ou extraordinaire” (deed in French)
Other provision: “Répartition_bénéfice_réserves, réduit_perte_reportée_ou_majoré_bénéfice_reporté” (deed in French)
Liquidation distribution: “Proportion actions, apurement dettes charges frais ou consignation” (deed in French)
Other provision: “Siège, communications sommations assignations significations” (deed in French)
Other provision: “Tribunaux_siège, compétence_judiciaire” (deed in French)
Other provision: “Droit commun, réputées_inscrites” (deed in French)
2 more provisions in the deed, see the deed of 22-06-2023

deed of 22-06-2023